(NAFB) — Elanco Animal Health has entered into a $7.6 billion agreement with Bayer to acquire its animal health business in a transaction valued at $7.6 billion. The transaction, which is subject to regulatory approval, will double Elanco’s companion animal business. Bayer CEO Werner Baumann says the acquisition by Elanco will “give rise to a leading competitor in the animal …
Elanco Seeks Injunction Against Deceptive rbST Advertising
Elanco initiated legal action last week in an eastern Wisconsin U.S. District Court against international dairy conglomerate Arla Foods last Friday. Elanco wants the court to force Arla to stop what it calls a deceptive advertising campaign and false business practices against rbST. It’s a supplement marketed and sold by Elanco under the brand name Prosilac. Elanco says the technology …